Renal transplantation in HIV-positive recipients

Current Infectious Disease Reports

Volumn 12, Issue 1, 2010, Pages 71-75

  Locke, Jayme E ^a   Segev, Dorry L ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Donor selection; Human Immunodeficiency Virus (HIV); Immunosuppression; Recipient selection; Renal transplantation

Indexed keywords

ALEMTUZUMAB; ANTIRETROVIRUS AGENT; ATAZANAVIR; BASILIXIMAB; CALCINEURIN INHIBITOR; CYCLOSPORIN; INTERLEUKIN 2 RECEPTOR ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; PROTON PUMP INHIBITOR; RAPAMYCIN; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; BLOOD GROUP ABO INCOMPATIBILITY; DRUG ANTAGONISM; GRAFT RECIPIENT; GRAFT SURVIVAL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DONOR; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MIXED INFECTION; PATIENT SELECTION; REVIEW; RISK FACTOR;

EID: 77349123984     PISSN: 15233847     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11908-009-0078-3     Document Type: Review

References (52)

1. UNAIDS: AIDS Epidemic Update 2006. Geneva: UNAIDS; 2006.
2. Centers for Disease Control and Prevention: HIV/AIDS Surveillance Report. Atlanta: Centers for Disease Control and Prevention; 2006.
3. CM Wyatt B Murphy 2005 Kidney transplantation in HIV-infected patients Semin Dial 18 495 498 16398712
4. V Pardo M Aldana RM Colton, et al. 1984 Glomerular lesions in the acquired immunodeficiency syndrome Ann Intern Med 101 429 434 1:STN:280:DyaL2czgsFCisw%3D%3D 6476632
5. TK Rao EJ Filippone AD Nicastri, et al. 1984 Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome N Engl J Med 310 669 673 1:STN:280:DyaL2c7kt1SrsA%3D%3D 6700641
6. MJ Ross PE Klotman 2002 Recent progress in HIV-associated nephropathy J Am Soc Nephrol 13 2997 3004 10.1097/01.ASN.0000040750.40907.99 12444220 (Pubitemid 35386920)
7. RM Selik RH Byers Jr MS Dworkin 2002 Trends in diseases reported on U.S. death certificates that mentioned HIV infection, 1987-1999 J Acquir Immune Defic Syndr 29 378 387 11917243
8. • Trullas JC, Barril G, Cofan F, et al.: Prevalence and clinical characteristics of HIV type 1-infected patients receiving dialysis in Spain: results of a Spanish survey in 2006: GESIDA 48/05 study. AIDS Res Hum Retroviruses 2008, 24:1229-1235. This article reports on a survey that was conducted across multiple dialysis centers in Spain. The study estimates that about 0.54% of dialysis patients have HIV. Of those, 61% are coinfected with hepatitis C and only 12% are registered on the kidney transplant waiting list.
9. AI Choi RA Rodriguez P Bacchetti, et al. 2007 Low rates of antiretroviral therapy among HIV-infected patients with chronic kidney disease Clin Infect Dis 45 1633 1639 10.1086/523729 18190326
10. • Fine DM, Perazella MA, Lucas GM, Atta MG: Renal disease in patients with HIV infection: epidemiology, pathogenesis and management. Drugs 2008, 68:963-980. This study discusses the varied kidney diseases that can impact HIV-positive patients, and stresses the importance of early identification and treatment.
11. M Rho MA Perazella 2007 Nephrotoxicity associated with antiretroviral therapy in HIV-infected patients Curr Drug Saf 2 147 154 10.2174/ 157488607780598269 1:CAS:528:DC%2BD2sXls1Glsb8%3D 18690961
12. V Shahinian S Rajaraman M Borucki, et al. 2000 Prevalence of HIV-associated nephropathy in autopsies of HIV-infected patients Am J Kidney Dis 35 884 888 10.1016/S0272-6386(00)70259-9 1:STN:280:DC%2BD3c3lsFWitQ%3D%3D 10793023
13. AH Cohen NC Sun P Shapshak DT Imagawa 1989 Demonstration of human immunodeficiency virus in renal epithelium in HIV-associated nephropathy Mod Pathol 2 125 128 1:STN:280:DyaL1M3msVCgsQ%3D%3D 2657719
14. MS Kumar DR Sierka AM Damask, et al. 2005 Safety and success of kidney transplantation and concomitant immunosuppression in HIV-positive patients Kidney Int 67 1622 1629 10.1111/j.1523-1755.2005.00245.x 15780120 (Pubitemid 40463144)
15. TS Ahuja M Borucki M Funtanilla, et al. 1999 Is the prevalence of HIV-associated nephropathy decreasing? Am J Nephrol 19 655 659 10.1159/000013537 1:STN:280:DC%2BD3c%2FotVKruw%3D%3D 10592359
16. JA Winston LA Bruggeman MD Ross, et al. 2001 Nephropathy and establishment of a renal reservoir of HIV type 1 during primary infection N Engl J Med 344 1979 1984 10.1056/NEJM200106283442604 1:STN:280: DC%2BD3MzntlGktw%3D%3D 11430327 (Pubitemid 32568152)
17. KC Abbott FC Trespalacios LY Agodoa TS Ahuja 2003 HIVAN and medication use in chronic dialysis patients in the United States: analysis of the USRDS DMMS Wave 2 study BMC Nephrol 4 5 10.1186/1471-2369-4-5 12837135
18. TS Ahuja J Grady S Khan 2002 Changing trends in the survival of dialysis patients with human immunodeficiency virus in the United States J Am Soc Nephrol 13 1889 1893 10.1097/01.ASN.0000019773.43765.BF 12089385 (Pubitemid 34700614)
19. PG Stock ME Roland 2007 Evolving clinical strategies for transplantation in the HIV-positive recipient Transplantation 84 563 571 10.1097/01.tp. 0000279190.96029.77 17876267 (Pubitemid 47429035)
20. HIV+ Solid Organ Transplant Multi-site Study: Transplant Study For People with HIV. Available at http://www.HIVtransplant.com. Accessed November 2009.
21. • Carlson L: Clinical management of the HIV-positive kidney transplant recipient. Nephrol Nurs J 2008, 35:559-567; quiz 568. This review article discusses the evolving clinical management of HIV-infected transplant recipients.
22. • Samuel D, Weber R, Stock P, et al.: Are HIV-infected patients candidates for liver transplantation? J Hepatol 2008, 48:697-707. This article discusses the susceptibility of HIV-positive patients to chronic diseases and the role of transplantation.
23. F Rouet A Inwoley DK Ekouevi, et al. 2006 CD4 percentages and total lymphocyte counts as early surrogate markers for pediatric HIV-1 infection in resource-limited settings J Trop Pediatr 52 346 354 10.1093/tropej/fml024 16782723 (Pubitemid 44542354)
24. • Jain M, Chakravarti A, Verma V, Bhalla P: Seroprevalence of hepatitis viruses in patients infected with the human immunodeficiency virus. Indian J Pathol Microbiol 2009, 52:17-19. This article highlights the importance of screening HIV-positive patients for hepatitis B and C coinfection before kidney transplantation.
25. O Lesens M Deschenes M Steben, et al. 1999 Hepatitis C virus is related to progressive liver disease in human immunodeficiency virus-positive hemophiliacs and should be treated as an opportunistic infection J Infect Dis 179 1254 1258 10.1086/314720 1:STN:280:DyaK1M3gvVOisg%3D%3D 10191232 (Pubitemid 29196510)
26. • Locke JE, Montgomery RA, Warren DS, et al.: Renal transplant in HIV-positive patients: long-term outcomes and risk factors for graft loss. Arch Surg 2009, 144:83-86. This retrospective study describes the importance of donor selection on long-term outcomes among HIV-positive kidney transplant recipients.
27. • Campara M, West-Thielke P, Thielke J, et al.: ABO incompatible renal transplantation in an HIV-seropositive patient. Transplantation 2008, 86:176-178. This case report describes the transplantation of an ABO-incompatible living donor kidney in an HIV-positive recipient.
28. PG Stock ME Roland L Carlson, et al. 2003 Kidney and liver transplantation in human immunodeficiency virus-infected patients: a pilot safety and efficacy study Transplantation 76 370 375 10.1097/01.TP.0000075973. 73064.A6 12883195 (Pubitemid 36928001)
29. • Roland ME, Barin B, Carlson L, et al.: HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomes. Am J Transplant 2008, 8:355-365. This article describes a prospective study of 18 HIV-positive kidney transplant recipients. The study demonstrates similar 1-year and 3-year patient and graft survival among HIV-positive and HIV-negative kidney transplant recipients.
30. KC Abbott SJ Swanson LY Agodoa PL Kimmel 2004 Human immunodeficiency virus infection and kidney transplantation in the era of highly active antiretroviral therapy and modern immunosuppression J Am Soc Nephrol 15 1633 1639 10.1097/01.ASN.0000127987.19470.3A 15153575 (Pubitemid 38679689)
31. • Gruber SA, Doshi MD, Cincotta E, et al.: Preliminary experience with renal transplantation in HIV+ recipients: low acute rejection and infection rates. Transplantation 2008, 86:269-274. This article describes a prospective study of eight HIV-positive kidney transplant recipients. The study demonstrated excellent long-term patient and graft survival and low acute rejection rates.
32. Pelletier SJ, Norman SP, Christensen LL, et al.: Review of transplantation in HIV patients during the HAART era. Clin Transpl 2004:63-82.
33. ME Roland PG Stock 2003 Review of solid-organ transplantation in HIV-infected patients Transplantation 75 425 429 10.1097/01.TP.0000046943.35335. 18 12605104 (Pubitemid 36241132)
34. HP Tan DJ Kaczorowski A Basu, et al. 2004 Living-related donor renal transplantation in HIV+ recipients using alemtuzumab preconditioning and steroid-free tacrolimus monotherapy: a single center preliminary experience Transplantation 78 1683 1688 10.1097/01.TP.0000145880.38548.0D 1:CAS:528:DC%2BD2cXhtVGqurnJ 15591960 (Pubitemid 39648444)
35. JC Trullas F Cofan S Cocchi, et al. 2007 Effect of thymoglobulin induction on HIV-infected renal transplant recipients: differences between HIV-positive and HIV-negative patients AIDS Res Hum Retroviruses 23 1161 1165 10.1089/aid.2007.0015 1:CAS:528:DC%2BD2sXht1Wls7jI 17961099 (Pubitemid 350014766)
36. • Frassetto LA, Tan-Tam C, Stock PG: Renal transplantation in patients with HIV. Nat Rev Nephrol 2009, 5:582-589. This article describes a comprehensive review that examines long-term outcomes among HIV-positive kidney transplant recipients and discusses clinical strategies for achieving these outcomes.
37. JT Carter ML Melcher LL Carlson, et al. 2006 Thymoglobulin-associated Cd4+ T-cell depletion and infection risk in HIV-infected renal transplant recipients Am J Transplant 6 753 760 10.1111/j.1600-6143.2006.01238.x 1:CAS:528:DC%2BD28XjslWntr8%3D 16539632
38. MM Hossain JJ Coull GL Drusano DM Margolis 2002 Dose proportional inhibition of HIV-1 replication by mycophenolic acid and synergistic inhibition in combination with abacavir, didanosine, and tenofovir Antiviral Res 55 41 52 10.1016/S0166-3542(02)00006-2 1:CAS:528:DC%2BD38XksFynsr0%3D 12076750 (Pubitemid 34655641)
39. A Karpas M Lowdell SK Jacobson F Hill 1992 Inhibition of human immunodeficiency virus and growth of infected T cells by the immunosuppressive drugs cyclosporin A and FK 506 Proc Natl Acad Sci U S A 89 8351 8355 10.1073/pnas.89.17.8351 1:CAS:528:DyaK38XmtVCls7c%3D 1381509
40. J Roy JS Paquette JF Fortin MJ Tremblay 2002 The immunosuppressant rapamycin represses human immunodeficiency virus type 1 replication Antimicrob Agents Chemother 46 3447 3455 10.1128/AAC.46.11.3447-3455.2002 1:CAS:528:DC%2BD38Xot1yktLk%3D 12384349 (Pubitemid 35192910)
41. • Roefs A, van der Ende M, IJzermans J, et al.: Long-term survival after kidney transplantation in an HIV-positive patient. Clin Transplant 2009, 23:278-281. This case report highlights an HIV-positive kidney transplant recipient with allograft survival beyond a decade.
42. JS Dummer S Erb MK Breinig, et al. 1989 Infection with human immunodeficiency virus in the Pittsburgh transplant population. A study of 583 donors and 1043 recipients, 1981-1986 Transplantation 47 134 140 10.1097/00007890-198901000-00030 1:STN:280:DyaL1M7gtFWrtw%3D%3D 2911869
43. R Kaur R Bedimo MB Kvanli, et al. 2006 A placebo-controlled pilot study of intensification of antiretroviral therapy with mycophenolate mofetil AIDS Res Ther 3 16 10.1186/1742-6405-3-16 16729890 (Pubitemid 44383156)
44. D Margolis A Heredia J Gaywee, et al. 1999 Abacavir and mycophenolic acid, an inhibitor of inosine monophosphate dehydrogenase, have profound and synergistic anti-HIV activity J Acquir Immune Defic Syndr 21 362 370 10.1097/01.pas.0000213299.11649.101 1:CAS:528:DC%2BD3cXjtl2ksbc%3D 10458616
45. DA Fruman CB Klee BE Bierer SJ Burakoff 1992 Calcineurin phosphatase activity in T lymphocytes is inhibited by FK 506 and cyclosporin A Proc Natl Acad Sci U S A 89 3686 3690 10.1073/pnas.89.9.3686 1:CAS:528:DyaK38Xkt1SisLo%3D 1373887
46. KJ Oestreich H Yoon R Ahmed JM Boss 2008 NFATc1 regulates PD-1 expression upon T cell activation J Immunol 181 4832 4839 1:CAS:528:DC%2BD1cXhtFarurnM 18802087
47. + T cells is the most important parameter for establishing prognosis in HIV-infected children.
48. SN Sehgal 2003 Sirolimus: its discovery, biological properties, and mechanism of action Transplant Proc 35 3 Suppl 7S 14S 10.1016/S0041-1345(03) 00211-2 1:CAS:528:DC%2BD3sXksFGqt78%3D 12742462 (Pubitemid 36547910)
49. LA Frassetto M Browne A Cheng, et al. 2007 Immunosuppressant pharmacokinetics and dosing modifications in HIV-1 infected liver and kidney transplant recipients Am J Transplant 7 2816 2820 10.1111/j.1600-6143.2007. 02007.x 1:CAS:528:DC%2BD2sXhsVGis7vM 17949460 (Pubitemid 350045781)
50. DJ Granville B Tashakkor C Takeuchi, et al. 2004 Reduction of ischemia and reperfusion-induced myocardial damage by cytochrome P450 inhibitors Proc Natl Acad Sci U S A 101 1321 1326 10.1073/pnas.0308185100 1:CAS:528: DC%2BD2cXhtlWjtb8%3D 14734800 (Pubitemid 38182687)
51. PP Fulco UB Vora GM Bearman 2006 Acid suppressive therapy and the effects on protease inhibitors Ann Pharmacother 40 1974 1983 1:CAS:528: DC%2BD28XhtlSlt7fE 17077173
52. AK Jain R Venkataramanan R Shapiro, et al. 2002 The interaction between antiretroviral agents and tacrolimus in liver and kidney transplant patients Liver Transpl 8 841 845 10.1053/jlts.2002.34880 12200788 (Pubitemid 35012297)